Commerzbank Aktiengesellschaft FI Makes New $274,000 Investment in GE HealthCare Technologies Inc. (NASDAQ:GEHC)

Commerzbank Aktiengesellschaft FI bought a new stake in shares of GE HealthCare Technologies Inc. (NASDAQ:GEHC) in the third quarter, Holdings Channel.com reports. The fund bought 2,923 shares of the company’s stock, valued at approximately $274,000.

A number of other hedge funds have also recently made changes to their positions in the stock. Vanguard Group Inc. boosted its position in GE HealthCare Technologies by 9.2% in the 1st quarter. Vanguard Group Inc. now owns 48,519,340 shares of the company’s stock valued at $4,410,893,000 after buying an additional 4,107,746 shares during the period. Bank of Montreal Can raised its stake in shares of GE HealthCare Technologies by 27.5% during the second quarter. Bank of Montreal Can now owns 696,446 shares of the company’s stock valued at $54,964,000 after acquiring an additional 150,137 shares in the last quarter. Sei Investments Co. boosted its holdings in shares of GE HealthCare Technologies by 30.6% in the first quarter. Sei Investments Co. now owns 279,336 shares of the company’s stock valued at $25,393,000 after purchasing an additional 65,476 shares during the period. Chevy Chase Trust Holdings LLC grew its stake in GE HealthCare Technologies by 7.1% in the first quarter. Chevy Chase Trust Holdings LLC now owns 235,436 shares of the company’s stock worth $21,403,000 after purchasing an additional 15,522 shares in the last quarter. Finally, BNP Paribas purchased a new position in GE HealthCare Technologies during the 1st quarter worth $30,000. 82.06% of the stock is currently owned by institutional investors.

Insider Buying and Selling at GE HealthCare Technologies

In other news, CEO Thomas J. Westrick sold 2,750 shares of the business’s stock in a transaction on Wednesday, August 7th. The shares were sold at an average price of $80.78, for a total transaction of $222,145.00. Following the sale, the chief executive officer now directly owns 17,509 shares of the company’s stock, valued at $1,414,377.02. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. 0.27% of the stock is currently owned by company insiders.

Wall Street Analysts Forecast Growth

Several equities research analysts have weighed in on GEHC shares. UBS Group cut GE HealthCare Technologies from a “neutral” rating to a “sell” rating and lowered their target price for the stock from $84.00 to $74.00 in a report on Thursday, September 26th. JPMorgan Chase & Co. assumed coverage on shares of GE HealthCare Technologies in a report on Monday, September 9th. They set a “neutral” rating and a $90.00 target price on the stock. Stifel Nicolaus boosted their price target on shares of GE HealthCare Technologies from $100.00 to $102.00 and gave the company a “buy” rating in a report on Monday, September 30th. Evercore ISI upped their price target on shares of GE HealthCare Technologies from $98.00 to $102.00 and gave the stock an “outperform” rating in a research report on Tuesday, October 1st. Finally, BTIG Research raised shares of GE HealthCare Technologies from a “neutral” rating to a “buy” rating and set a $100.00 price objective on the stock in a report on Wednesday, September 18th. One investment analyst has rated the stock with a sell rating, five have assigned a hold rating, seven have assigned a buy rating and one has issued a strong buy rating to the company. According to data from MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average price target of $94.23.

GE HealthCare Technologies Stock Performance

Shares of GEHC opened at $88.90 on Friday. The company has a current ratio of 1.06, a quick ratio of 0.82 and a debt-to-equity ratio of 1.05. The firm has a market cap of $40.58 billion, a PE ratio of 25.99, a P/E/G ratio of 3.39 and a beta of 1.18. GE HealthCare Technologies Inc. has a 12 month low of $62.35 and a 12 month high of $94.55. The stock has a fifty day moving average price of $88.35 and a 200-day moving average price of $83.45.

GE HealthCare Technologies (NASDAQ:GEHC) last released its quarterly earnings results on Wednesday, July 31st. The company reported $1.00 EPS for the quarter, beating analysts’ consensus estimates of $0.98 by $0.02. GE HealthCare Technologies had a return on equity of 25.26% and a net margin of 8.10%. The company had revenue of $4.84 billion during the quarter, compared to analysts’ expectations of $4.88 billion. During the same period last year, the business posted $0.92 earnings per share. The firm’s revenue was up .5% compared to the same quarter last year. Equities research analysts predict that GE HealthCare Technologies Inc. will post 4.26 earnings per share for the current fiscal year.

GE HealthCare Technologies Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, November 15th. Shareholders of record on Friday, October 18th will be given a dividend of $0.03 per share. This represents a $0.12 annualized dividend and a yield of 0.13%. The ex-dividend date is Friday, October 18th. GE HealthCare Technologies’s dividend payout ratio is presently 3.51%.

About GE HealthCare Technologies

GE HealthCare Technologies Inc engages in the development, manufacture, and marketing of products, services, and complementary digital solutions used in the diagnosis, treatment, and monitoring of patients in the United States, Canada, and internationally. The company operates through four segments: Imaging, Ultrasound, Patient Care Solutions, and Pharmaceutical Diagnostics.